Effectiveness of Acupuncture for Depressed Patients Not Taking Antidepressant Medications
Primary Purpose
Depression
Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Acupuncture
Sponsored by

About this trial
This is an interventional treatment trial for Depression focused on measuring Acupuncture, Antidepressant, Monotherapy, Depression, Alternative treatments
Eligibility Criteria
Inclusion Criteria:
- Has current or past DSM-IV MDD diagnosis based on SCID; AND current 17-Hamilton Rating Scale for Depression (BRSD) score of 14 or above
- Age between 18-65
- No treatment with antidepressant(s) in the past 3 months
- If patient has received psychotherapy, no initiation or termination of therapy in the past 3 months.
Exclusion Criteria:
- Patients with primary diagnosis other than Major Depressive Disorder, or any history of psychosis or mania.
- Conditions that could make it difficult to conclusively determine that depressive symptoms were the result of MDD and not some other condition, including substance abuse or dependence within the last 6 months, medical conditions that could produce depression, including epilepsy, history of an abnormal EEG, severe head trauma, or stroke.
- Serious uncontrolled medical conditions [e.g. poorly controlled diabetes, severe congestive heart failure], or other medical conditions that have not been stable for at least 3 months.
- Electroconvulsive therapy (ECT) during the last year.
- Current active suicidal or self-injurious potential necessitating immediate treatment.
- Currently receiving concomitant Acupuncture Treatment, or any Acupuncture treatment in the past three months.
Sites / Locations
- Depression Clinical and Research Program, Massachusetts General Hospital
Arms of the Study
Arm 1
Arm Type
Experimental
Arm Label
Acupuncture
Arm Description
Adults with depression who are not currently taking an antidepressant medication.
Outcomes
Primary Outcome Measures
Change in scores on the Hamilton Depression Rating Scale, 17 items (HAM-D-17)
The HAM-D-17 is a clinician-rated assessment (structured interview) of patients' depressive symptoms. Questions focus on depressive symptoms during the past 7 days, and higher cumulative scores (possible responses to each item range from 0-4 or 0-2) indicate more severe depression.
Secondary Outcome Measures
Response to treatment, defined as a 50% or greater improvement in HAM-D-17 score compared to baseline
(See primary outcome measure description.)
Full Information
NCT ID
NCT01634022
First Posted
June 15, 2012
Last Updated
July 2, 2012
Sponsor
Massachusetts General Hospital
1. Study Identification
Unique Protocol Identification Number
NCT01634022
Brief Title
Effectiveness of Acupuncture for Depressed Patients Not Taking Antidepressant Medications
Official Title
Effectiveness of Acupuncture on Treating Major Depressive Disorder
Study Type
Interventional
2. Study Status
Record Verification Date
July 2012
Overall Recruitment Status
Completed
Study Start Date
May 2005 (undefined)
Primary Completion Date
November 2011 (Actual)
Study Completion Date
November 2011 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Massachusetts General Hospital
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
Acupuncture is a popular complementary/alternative therapy that has been in use for thousands of years for the treatment of various medical and psychiatric conditions, including Major Depressive Disorder (MDD). In this study, the investigators applied the investigators acupuncture-treatment-for-depression protocol, based on Traditional Chinese Medicine (TCM) principles for treating MDD, to depressed patients not taking any antidepressant medications (a protocol that the investigators previously piloted as a medication augmentation therapy for partial responders with MDD).
The investigators specifically investigated the efficacy, safety, and tolerability of this TCM-based protocol for such patients, as well as potential differences in outcomes between weekly vs. twice-weekly treatment. The investigators hypothesized that acupuncture monotherapy would be associated with a response rate of at least 50%, which the investigators defined as a decrease in depressive symptoms from the beginning to the end of the study of 50% or more, and that the response would be greater among patients who received acupuncture 2 times per week (vs. 1 time per week). The investigators also hypothesized that acupuncture would be associated with minimal side effects.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Depression
Keywords
Acupuncture, Antidepressant, Monotherapy, Depression, Alternative treatments
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
64 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Acupuncture
Arm Type
Experimental
Arm Description
Adults with depression who are not currently taking an antidepressant medication.
Intervention Type
Procedure
Intervention Name(s)
Acupuncture
Intervention Description
5 specific body acupoints (HT-7 and LI-4 on the hands bilaterally, and ST-36, SP-6, and LR-3 on the legs bilaterally) with gentle manual tonification every 10 min. Two acupoints along the midline of the head, GV-20 and GV-24.5 (Yintang), were also used with a 2 Hz current applied from GV-20 (-) to GV24.5 (+).
Primary Outcome Measure Information:
Title
Change in scores on the Hamilton Depression Rating Scale, 17 items (HAM-D-17)
Description
The HAM-D-17 is a clinician-rated assessment (structured interview) of patients' depressive symptoms. Questions focus on depressive symptoms during the past 7 days, and higher cumulative scores (possible responses to each item range from 0-4 or 0-2) indicate more severe depression.
Time Frame
Baseline and all acupuncture sessions (weekly) for 8 weeks
Secondary Outcome Measure Information:
Title
Response to treatment, defined as a 50% or greater improvement in HAM-D-17 score compared to baseline
Description
(See primary outcome measure description.)
Time Frame
Baseline and all acupuncture sessions (weekly) for 8 weeks
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
65 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Has current or past DSM-IV MDD diagnosis based on SCID; AND current 17-Hamilton Rating Scale for Depression (BRSD) score of 14 or above
Age between 18-65
No treatment with antidepressant(s) in the past 3 months
If patient has received psychotherapy, no initiation or termination of therapy in the past 3 months.
Exclusion Criteria:
Patients with primary diagnosis other than Major Depressive Disorder, or any history of psychosis or mania.
Conditions that could make it difficult to conclusively determine that depressive symptoms were the result of MDD and not some other condition, including substance abuse or dependence within the last 6 months, medical conditions that could produce depression, including epilepsy, history of an abnormal EEG, severe head trauma, or stroke.
Serious uncontrolled medical conditions [e.g. poorly controlled diabetes, severe congestive heart failure], or other medical conditions that have not been stable for at least 3 months.
Electroconvulsive therapy (ECT) during the last year.
Current active suicidal or self-injurious potential necessitating immediate treatment.
Currently receiving concomitant Acupuncture Treatment, or any Acupuncture treatment in the past three months.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Albert Yeung, MD, ScD
Organizational Affiliation
Depression Clinical and Research Program, Massachusetts General Hospital
Official's Role
Principal Investigator
Facility Information:
Facility Name
Depression Clinical and Research Program, Massachusetts General Hospital
City
Boston
State/Province
Massachusetts
ZIP/Postal Code
02114
Country
United States
12. IPD Sharing Statement
Citations:
PubMed Identifier
22521855
Citation
Mischoulon D, Brill CD, Ameral VE, Fava M, Yeung AS. A pilot study of acupuncture monotherapy in patients with major depressive disorder. J Affect Disord. 2012 Dec 10;141(2-3):469-73. doi: 10.1016/j.jad.2012.03.023. Epub 2012 Apr 21.
Results Reference
result
Learn more about this trial
Effectiveness of Acupuncture for Depressed Patients Not Taking Antidepressant Medications
We'll reach out to this number within 24 hrs